DIPLOMA IN CLINICAL MEDICINE PAST PAPER ON COMMUNICATION SKILLS
| Institution | Kenya Medical Training College |
| Course | DIPLOMA IN CLINICAL... |
| Year | 1st Year |
| Semester | Unknown |
| Posted By | stephen oyake rabilo |
| File Type | |
| Pages | 5 Pages |
| File Size | 1.39 MB |
| Views | 1020 |
| Downloads | 0 |
| Price: |
Buy Now
|
Below is the document preview.
Sinus Mechanisms
A normal heartbeat results from an electrical impulse that originates from the hearts primary pace maker-(SA node)
• The Normal sinus rhythm records the hearts electrical impulse that starts in the SAN spreading through the normal conduction pathway.
• The SAN dominates other areas that may pace the heart slower and abnormally.
All other rhythms will be compared to the Normal Sinus
Rhythm
44 Pages
1104 Views
0 Downloads
1.72 MB
Ventricular Rhythms
The ventricles (purkinje fibres) may assume the function of pacing the heart, they pace at a slower rate 20-40b/min which cannot sustain the body's perfusion requirements. Rhythms originating from the ventricles are called ventricular arrhythmias because they originate in the ventricles.
Ventricular arrhythmias occur when:-
a) The SAN fails to initiate an impulse
b) The AVN does not pick to pace
c) There is an irritable foci in the ventricular muscle
61 Pages
1112 Views
0 Downloads
2.42 MB
Sickle cell Crisis
Sickle cell disease (SCD)
• A group of hereditary disorders in which the normal adult hemoglobin (hemoglobin A) is partly or completely replaced by abnormal sickle hemoglobin (HgbS).
• The most common genetic hematologic condition in children
• Transmitted by autosomal recessive pattern of inheritance.
• Patient with this condition is homozygous for the sickle cell gene, i.e. both genes are abnormal.
• The basic defect responsible for the sickling of
erythrocytes is contained in the globin fraction of hemoglobin
• The mode of transmission is hereditary
• The gene that determines the production of HgbS is situated on an autosome.
47 Pages
999 Views
0 Downloads
833.89 KB
Treatment modalities for hematological disorders
These are therapies aimed at preventing, alleviating the underlying cause or treating the hematological disorder
• They include
1. Nutritional therapy: meal management to ensure rich sources of iron, vitamin K, vitamin B9.
2. Supplements: administration of folate, iron sulfate.
3. Treatment of underlying cause: antimalarial, deworming, ulcer treatment
21 Pages
1009 Views
0 Downloads
318.84 KB
Valvular heart disease
Outline
1. Review the role of valves in cardiac cycle
2. Define valvular heart disease
3. Identify types of VHD
4. Explain the assessment and diagnostic tests
5. Describe the management of patient with VHD
46 Pages
851 Views
0 Downloads
680.83 KB
Assessment and diagnostic evaluation of patient with haematological disorder
History taking
1. Nutrition: feeding habits; typical meal – to determine deficiencies
2. use of prescription and over-the-counter medications: most hematological conditions can result from herbs, or certain medications.
3. Prior chemotherapy or radiotherapy
16 Pages
952 Views
0 Downloads
372.41 KB
Disseminated intravascular coagulation (DIC)
It is a condition of combine platelet and coagulation factor disorder.
• It is characterized by widespread coagulation and bleeding in the vascular compartment.
• DIC occurs secondary to inappropriate systemic activation of normal clotting mechanisms.
• It is associated with underlying disease manifested as uncontrolled activation of coagulation and fibrinolysis.
21 Pages
957 Views
0 Downloads
309.13 KB
Circulatory Shock
3 elements ensures adequate tissue perfusion
1. Functioning pump (myocardial contractility)
2. Rate of Myocardial contraction
3. Adequate volume of blood (preload)
4. Normal vascular tone, SVR (Afterload)
• In order for adequate tissue perfusion to occur, cardiac output must be sufficient to deliver nutrient- and oxygen rich blood to the tissues.
67 Pages
998 Views
0 Downloads
803.9 KB
Hematologic emergencies (Disorders of haemostasis)
Disorders of hemostasis – hypercoagulability
states
Disorders occurring due to imbalance between procoagulants and anticoagulants.
Pro-coagulant factors:
Platelets
clotting factors
Ca2 PLUS
molecules released by damaged tissues
Anticoagulant factors
Protein C
Plasmin
Antithrombin III
35 Pages
996 Views
0 Downloads
718.58 KB
Leukemia
A group of malignant diseases of the bone marrow and lymphatic system.
• Characterized by an unrestricted proliferation of immature white blood cells in the blood-forming tissues of the body.
• Classified as malignant because the leukemic cells demonstrate the neoplastic properties of solid cancers.
15 Pages
824 Views
0 Downloads
428.22 KB